IRCT20190106042262N1已完成3 期
Compare the efficacy of combination Deferasirox and Deferiprone with Deferoxamine and Deferiprone in reducing heart and liver iron load in patients with transfusion-Dependent ß-Thalassemia.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 years 至 no limit（—）
- 性别
- All
入选标准
- •All Patients with transfusion-Dependent ß-Thalassemia with ferritin more than 1000
- •All Patients with transfusion-Dependent ß-Thalassemia who were not treated with combination iron chelators
- •All Patients with transfusion-Dependent ß-Thalassemia with heart and liver iron load
- •All Patients with transfusion-Dependent ß-Thalassemia with normal liver and renal function
- •All Patients with transfusion-Dependent ß-Thalassemia with age more than 10 years
排除标准
- •Gastrointestinal problem before research
研究者
相似试验
招募中
不适用
Efficay comparison two oral chelators combination in patients with beta-thalassemiaIRCT20160310026998N7Tabriz University of Medical Sciences54
已完成
2 期
Effect of Osveral on iron overload in beta thalassemia major patients.beta thalassemia.beta thalassemiaIRCT2015102524679N2Investigator69
已完成
不适用
?Exir research project of desferoxamin with brand name of Deferoxirthalassemia major.Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia majorIRCT2015012620818N1exir pharmacutical company100
尚未招募
4 期
Bioequivalence Study of 500 mg Deferasirox Dispersible Tablets in Healthy Thai under Fasting ConditioBioequivalence studyTCTR20170222005Research and Development36
已完成
Unknown
Comparison of Deferazirox and Deferoxamine on Serum Ferritin Levels Changes in Major Beta Thalassemia PatientsIRCT20190817044550N4Birjand University of Medical Sciences45